(Q48350364)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

0 references

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Srihari Gopal

1 reference

ORCID Public Data File 2021

author name string

S Gopal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

U Vijapurkar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

P Lim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Eerdekens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

D Hough

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

8 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

7 February 2020

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

685-697

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20615933%20AND%20SRC:MED&resulttype=core&format=json

A rating scale for drug-induced akathisia

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Antipsychotic medication adherence in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Tactics and technologies to manage nonadherence in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Weight changes with depot neuroleptic maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Antipsychotic agents. Gradually improving treatment from the traditional oral neuroleptics to the first atypical depot

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Risperidone long-acting injection: a review of its long term safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817

Guidelines for depot antipsychotic treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372817